No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Immunic Stock (NASDAQ:IMUX): Exploring the Promising Phase 2 CALLIPER Trial
Express News | Piper Sandler Reiterates Overweight on Immunic, Maintains $28 Price Target
Immunic Analyst Ratings
Immunic Names Jason Tardio as COO, Werner Gladdines as Chief Development Officer
Express News | Immunic- Jason Tardio Will Be Joining Co as Chief Operating Officer & President Effective July 12 2024
Express News | Immunic Appoints Jason Tardio as Chief Operating Officer and President